Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
about
Actomyosin stress fiber mechanosensing in 2D and 3DActin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells.The role of myosin II in glioma invasion: A mathematical model.Cellular force assay detects altered contractility caused by a nephritis-associated mutation in nonmuscle myosin IIA.Modular regulation of Rho family GTPases in development.Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration.DT-13 Ameliorates TNF-α-Induced Vascular Endothelial Hyperpermeability via Non-Muscle Myosin IIA and the Src/PI3K/Akt Signaling PathwayCBP-mediated SMN acetylation modulates Cajal body biogenesis and the cytoplasmic targeting of SMN.Cell migration, intercalation and growth regulate mammalian cochlear extension.High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell derived neurons.Cardiomyocytes Sense Matrix Rigidity through a Combination of Muscle and Non-muscle Myosin Contractions.MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development.Localized Myosin II Activity Regulates Assembly and Plasticity of the Axon Initial Segment.Accumulation of poly(A) RNA in nuclear granules enriched in Sam68 in motor neurons from the SMNΔ7 mouse model of SMA.Using Drosophila to study mechanisms of hereditary hearing loss.Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary diseaseVimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma CellsGetting site-specific with actomyosin inhibitors
P2860
Q28074623-6757D9F4-0F96-4624-847D-B267C6254294Q30852504-19E5F233-EA4C-4052-B920-E2D79540A0A8Q36271552-238D22AE-7C09-491A-BFF1-2EAC8A1F85F9Q38676040-EF0592F1-40AB-4E60-9496-662FBE27695EQ39183594-82184DE6-9BFF-4D95-95FD-25C44127CFF3Q39314105-01007360-D7E9-4614-B4D9-56A4E05BC005Q41418721-2CE31EE2-8ECB-4234-82B1-A7B759E69C5FQ47569536-06CC8C9A-ADDC-40EC-865C-1DED92394E8CQ47857643-C952F8DF-47E7-4039-89A5-FC8F00E973F7Q48183777-6F4A796D-91C8-4837-A11D-EFC513707C15Q49288611-DA4DE615-A7AD-4C2B-B5A4-4D108C15BD40Q49513418-266D440C-4604-484C-930A-E39D7D7BFDDEQ50207604-A0E78475-8B37-437D-ADA1-A1F9381D46C5Q55511978-3885E8D7-C70E-4C1D-813E-99F1D1F2829EQ55519023-F5769485-9765-47E7-AF00-6189E8EA6ABBQ58617563-CF7C080A-FBE5-4365-A60C-601BEA344682Q58694775-2E14A8D9-4D86-4895-B3F3-953FEACCCFD0Q58802237-2CCCB7F9-4AE9-4018-9F76-D9E238C01E47
P2860
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@ast
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@en
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@nl
type
label
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@ast
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@en
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@nl
prefLabel
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@ast
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@en
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@nl
P2860
P921
P3181
P356
P1476
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
@en
P2093
Rick Horwitz
P2860
P304
P3181
P356
10.1242/DMM.022103
P407
P577
2015-11-05T00:00:00Z
2015-12-01T00:00:00Z